US Investigational new drug application (IND) for Sativex®

A cannabis derived drug which has been approved in some countries to treat muscle spasticity.

US Investigational new drug application (IND) for Sativex®

Postby MSUK » Wed Aug 14, 2013 2:56 am

US Investigational new drug application (IND) for Sativex® phase 3 clinical program for MS spasticity

GW Pharmaceuticals plc announced today that it has opened a Phase 3 Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to conduct a pivotal efficacy and safety clinical program to evaluate Sativex® for the treatment of spasticity due to Multiple Sclerosis (MS). Sativex is currently approved in 22 countries outside the U.S. as a treatment for MS spasticity....... Read More - http://www.ms-uk.org/index.cfm/sativex
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2109
Joined: Wed Oct 14, 2009 3:00 pm

Return to Sativex

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service